Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,000,000 shares, an increase of 18.6% from the April 15th total of 2,530,000 shares. Based on an average daily trading volume, of 598,700 shares, the short-interest […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totalling 3,000,000 shares, an increase of 18.6% from the April 15th total of 2,530,000 shares. Based on an average trading volume of 598,700 shares, the short-interest ratio […]
Fulcrum Therapeutics (NASDAQ:FULC) Upgraded to Buy by The Goldman Sachs Group dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Fulcrum Therapeutics (NASDAQ:FULC) Stock Price Down 6 2% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the target of some unusual options trading on Monday. Stock traders acquired 21,436 call options on the stock. This represents an increase of approximately 9,180% compared to the average volume of 231 call options. Analysts Set New Price Targets A number of research analysts have recently […]